Advertisement
Advertisement
U.S. Markets open in 1 hr 26 mins
Advertisement
Advertisement
Advertisement
Advertisement

F-star Therapeutics, Inc. (FSTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.600.00 (0.00%)
At close: 04:00PM EDT
6.45 -0.15 (-2.27%)
Pre-Market: 08:00AM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/9/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.36
52 Week Low 32.07
50-Day Moving Average 35.23
200-Day Moving Average 34.46

Share Statistics

Avg Vol (3 month) 3367.9k
Avg Vol (10 day) 3169.03k
Shares Outstanding 520.62M
Implied Shares Outstanding 6N/A
Float 821.08M
% Held by Insiders 14.16%
% Held by Institutions 152.35%
Shares Short (Jul 14, 2022) 4220.37k
Short Ratio (Jul 14, 2022) 40.29
Short % of Float (Jul 14, 2022) 41.03%
Short % of Shares Outstanding (Jul 14, 2022) 41.02%
Shares Short (prior month Jun 14, 2022) 4277.83k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 22, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -161.70%
Operating Margin (ttm)-150.27%

Management Effectiveness

Return on Assets (ttm)-23.24%
Return on Equity (ttm)-54.69%

Income Statement

Revenue (ttm)20.8M
Revenue Per Share (ttm)1.06
Quarterly Revenue Growth (yoy)-12.50%
Gross Profit (ttm)21.17M
EBITDA -30.67M
Net Income Avi to Common (ttm)-33.64M
Diluted EPS (ttm)-2.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.8M
Total Cash Per Share (mrq)3.2
Total Debt (mrq)13.05M
Total Debt/Equity (mrq)14.81
Current Ratio (mrq)6.11
Book Value Per Share (mrq)4.37

Cash Flow Statement

Operating Cash Flow (ttm)-24.5M
Levered Free Cash Flow (ttm)-13.63M
Advertisement
Advertisement